Selected Grants
Magnitude
Clinical TrialPrincipal Investigator · Awarded by Intellia Therapeutics, Inc. · 2024 - 2029Identification of Host-Specific Determinants of APOL1-associated COVAN
ResearchAdvisor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of JK07 in Adults With Chronic Heart Failure
Clinical TrialPrincipal Investigator · Awarded by Salubris Biotherapeutics, Inc. (SalubrisBio) · 2024 - 2027Myovascular interactions stimulate cardiac regeneration in self-assembling cardiac organoids
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2027Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027Training Program in Developmental and Stem Cell Biology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2001 - 2027A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication
Clinical TrialPrincipal Investigator · Awarded by Alnylam Pharmaceuticals · 2022 - 2026Myovascular Mechanisms of Cardiac Growth and Regeneration
ResearchPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2026Repurposing 99mTc-tilmanocept Imaging for Cardiac Sarcoidosis
ResearchPrincipal Investigator · Awarded by The Foundation for Sarcoidosis Research · 2024 - 2026Cardiac organoids to model myovascular interactions (Parker, Lauren)
FellowshipPrincipal Investigator · Awarded by American Heart Association · 2024 - 2026Cell and Molecular Biology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Mechanisms Regulating Vascular Homeostasis
ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2021 - 2025Epithelioid Mechanisms of Sarcoidosis
ResearchPrincipal Investigator · Awarded by Ann Theodore Foundation · 2022 - 2025Printed Electronic Biosensors for Point-of-Care Testing of Cardiovascular Biomarkers
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2025Multidisciplinary Heart and Vascular Diseases
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1975 - 2023MYK-461-019 (EMBARK)
Clinical TrialPrincipal Investigator · Awarded by MyoKardia, Inc. · 2021 - 2023Angiogenic Approaches to Stimulate Heart Regeneration
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2020Oral Doses of MYK-491 in Patients with Stable Heart Failure
Clinical TrialPrincipal Investigator · Awarded by MyoKardia, Inc. · 2018 - 2020AMG 986_20150183
Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2018 - 2019BMS-986231_Heart Failure
Clinical TrialPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2018 - 2019IW-1973 Caplet
Clinical TrialPrincipal Investigator · Awarded by Ironwood Pharmaceuticals, Inc. · 2017 - 2019Biomarkers of Heart Regeneration
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2018A Phase 2a Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses of MEDI6012 in Subjects with Stable Coronary Artery Disease
Clinical TrialPrincipal Investigator · Awarded by MedImmune, Inc. · 2015 - 2016External Relationships
- Alnylam
- Arcturus
- McGraw-Hill Publishing
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.